NCT05540236

Brief Summary

Auricular acupressure is easily accessible and easily performed, and can significantly relieve PONV symptoms, and improve patient's satisfaction in women receiving general anesthesia for gynecological surgeries. This makes it an economically-beneficial supplemental therapy, worthy of promoting for patients receiving general anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 18, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 14, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 14, 2022

Completed
Last Updated

September 14, 2022

Status Verified

July 1, 2022

Enrollment Period

10 months

First QC Date

August 14, 2022

Last Update Submit

September 12, 2022

Conditions

Keywords

gynecological laparoscopic surgeryauricular acupressurecomplementary therapyPONVgeneral anesthesia

Outcome Measures

Primary Outcomes (1)

  • Rhodes Index of Nausea, Vomiting, and Retching

    This tool is divided into self-assessment and observation, with 8 total questions, each with 5 score values (0 to 4 points), for a maximum score of 32 points. 3 of the questions evaluate the amount, frequency and severity of vomiting, accounting for up to 12 points. 3 of the questions evaluate the frequency and severity of nausea, accounting for up to 12 points. 2 of the questions evaluate the frequency and severity of retching, accounting for up to 8 points. The higher the total score, the more severe the symptoms. The Cronbach's alpha of the original tool is 0.89-0.97, the Cronbach's alpha of prospective studies was 0.85 (Rhodes \& McDaniel, 1999), while the Cronbach's alpha of Chou et al. (2005) for the Chinese version of the Rhodes Index of Nausea, Vomiting and Retching(RINV) was 0.94, with content validity index (CVI) of 1.0.

    24hours after ear auricular acupressure

Secondary Outcomes (2)

  • Hospital Anxiety and Depression Scale: Anxiety- (HADS-A)

    24hours after ear auricular acupressure

  • Post-anesthesia care satisfaction

    24hours after ear auricular acupressure

Study Arms (2)

The experimental group were given therapeutic intervention

EXPERIMENTAL

The experimental group were given therapeutic intervention of single ear auricular pellet acupressure at the stomach(CO4), cardia(CO3), liver(CO12), occiput(AT3), shenmen(TF4) and subcortex(AT4) acupuncture points

Other: auricular acupressure

The control group were given sham intervention

PLACEBO COMPARATOR

The control group were given sham intervention of single ear auricular pellet acupressure at the knee(AH4) and thoracic vertebrae(AH11) acupuncture points

Other: sham auricular acupressure

Interventions

The experimental group were given therapeutic intervention of single ear auricular pellet acupressure at the stomach(CO4), cardia(CO3), liver(CO12), occiput(AT3), shenmen(TF4) and subcortex(AT4) acupuncture points

The experimental group were given therapeutic intervention

The control group were given sham intervention of single ear auricular pellet acupressure at the knee(AH4) and thoracic vertebrae(AH11) acupuncture points

The control group were given sham intervention

Eligibility Criteria

Age20 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years,Female
  • ASA(Amersican Society of Anesthesiologists):I or II
  • Gynecological laparoscopic patients receiving general anesthesia with endotracheal tube and volatile anesthetics (Desflurane or Sevoflurane)
  • Clear consciousness, willing and able to sign permit agreeing to participate in the study

You may not qualify if:

  • Allergic skin condition or damaged skin at planned auricular pellet site.
  • Unplanned admission to Intensive Care Unit
  • Retained endotracheal tube upon entry to post-operative care unit
  • Postoperative use of patient-controlled analgesia
  • Diagnosis of malignancy
  • Anti-emetics: Use of Novamin of 3 or more times.
  • Patient who fulfill the criteria of Non-smoker, motion sickness, and history of PONV

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cathay General Hospital

Taipei, Taiwan

Location

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 14, 2022

First Posted

September 14, 2022

Study Start

July 18, 2021

Primary Completion

May 20, 2022

Study Completion

May 20, 2022

Last Updated

September 14, 2022

Record last verified: 2022-07

Locations